Comparative Pharmacology
Head-to-head clinical analysis: PENICILLIN G SODIUM versus VEETIDS 250.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PENICILLIN G SODIUM versus VEETIDS 250.
PENICILLIN G SODIUM vs VEETIDS '250'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Penicillin G inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.
VEETIDS '250' is an oral cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), particularly PBP-3, thereby disrupting peptidoglycan cross-linking and leading to cell lysis.
2-4 million units intravenously every 4 hours for moderate to severe infections; up to 24 million units/day for severe infections (e.g., meningitis, endocarditis).
250 mg orally every 8 hours for 7-10 days
None Documented
None Documented
30-60 minutes in normal renal function; prolonged to 7-10 hours in anuria.
2-3 hours in adults with normal renal function; prolonged to 24-40 hours in anuria/end-stage renal disease, requiring dose adjustment.
Primarily renal (60-90% unchanged) via glomerular filtration and tubular secretion; minor biliary/fecal (<10%).
Primarily renal (≥90% as unchanged drug) via glomerular filtration and tubular secretion; minor biliary/fecal (<5%).
Category A/B
Category C
Penicillin Antibiotic
Penicillin Antibiotic